<!doctype html>
<html lang="fr">
<head>
  <meta charset="utf-8">
  <meta content="width=device-width,initial-scale=1" name=viewport>
  <title>Ethypharm UK - F.A.Q</title>
  <link rel="stylesheet" href="main.css">
</head>
<body>

	<!-- HEADER -->
	<div class="container-fluid">
		<div class="row">

			<div class="col-xs-12">
			<header>

				<!-- LOGO + Contact link -->
				<div class="row">
					<div class="logobar">
						<div class="nav-icon js-nav hidden-lg hidden-md"><i class="i-nav-icon"></i><i class="i-close hidden"></i></div>
						<div class="logobar-logo"><a href="homepage.html"><span></span></a></div>
					</div>
				</div>

				<!-- DOUBLE NAV -->
				<div class="row">
					<div class="navbar-wrapper">
						<nav class="navbar navbar--public">
							<ul class="nav-left">
								<li class="navbar-item-title"><a href="homepage-pro.html">Professionals</a></li>
							</ul><!--
						--><ul class="nav-right">
								<li class="navbar-item-title">Patients</li>
								<li><a href="therapeutic-areas.html">Products</a></li>
								<li><a href="faq.html">Frequently asked questions</a></li>
								<li><a href="contact.html">Contact</a></li>
							</ul>
						</nav>
					</div>
				</div>	

			</header>
			</div>

		</div>

	</div>

	
	<div class="container-fluid">
		<div class="row">
			<div class="topbanner" style="background-image: url(img/banner-faq.jpg);">
				<div class="topbanner-title">Frequently Asked Questions</div>
			</div>
		</div>
	</div>
	
	<div class="container">

		<div class="row">
			<div class="col-xs-12 hidden-xs">
				<div class="breadcrumb"><a href="homepage.html">Home</a> / <a href="homepage-public.html">Patients</a> / <a href="faq.html">FAQ</a></div>
			</div>

			<div class="col-xs-12">
				<h1>Frequently Asked Questions</h1>
			</div>
		</div>

		<div class="row">

			<div class="col-xs-12 filter-selector">
				<div class="filter-selector-label">Filter questions by product</div>

				<input id="select-type-all" name="radio-set-1" type="radio" class="filter-selector-all" checked="checked" /><label for="select-type-all" class="filter-label-all">All products</label>
				<input id="select-type-1" name="radio-set-1" type="radio" class="filter-selector-1" /><label for="select-type-1" class="filter-label-1">Abtard</label>
				<input id="select-type-2" name="radio-set-1" type="radio" class="filter-selector-2" /><label for="select-type-2" class="filter-label-2">Ebesque XL</label>
				<input id="select-type-3" name="radio-set-1" type="radio" class="filter-selector-3" /><label for="select-type-3" class="filter-label-3">Fencino</label>
				<input id="select-type-5" name="radio-set-1" type="radio" class="filter-selector-5" /><label for="select-type-5" class="filter-label-5">Venlalic XL</label>
				<input id="select-type-6" name="radio-set-1" type="radio" class="filter-selector-6" /><label for="select-type-6" class="filter-label-6">Others</label>

				<div class="collapsing-faq" id="accordion" role="tablist" aria-multiselectable="true">
				  
				  <div class="collapsing-item filter-selector-1">
				    <div class="collapsing-heading" role="tab" id="heading1">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse1" aria-expanded="false" aria-controls="collapse1">
				          <span class="collapsing-headingName">Abtard</span>
				          <span class="collapsing-headingQuestion">Are the tablet film coated?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse1" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading1">
				      <div class="collapsing-body">
				        <p>Yes they are.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-1">
				    <div class="collapsing-heading" role="tab" id="heading2">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse2" aria-expanded="false" aria-controls="collapse2">
				          <span class="collapsing-headingName">Abtard</span>
				          <span class="collapsing-headingQuestion">Are 2 x 60mg tablets bioequivalent to a single 120mg strength of Oxycontin?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse2" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading2">
				      <div class="collapsing-body">
				        <p>There are no bioequivalence studies for Abtard 2 x 60mg versus one single dose of 120mg of OxyContin.  It is a matter of clinical judgement for the prescriber to decide whether 2 x 60mg tablets can be used.  What our bioequivalence studies prove is that Abtard 60mg is bioequivalent to OxyContin 60mg, in practice if a retail pharmacist received a prescription for a 120mg of OxyContin and only had the 60mg OxyContin available would they give 2 x 60mg tablets.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-1">
				    <div class="collapsing-heading" role="tab" id="heading3">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse3" aria-expanded="false" aria-controls="collapse3">
				          <span class="collapsing-headingName">Abtard</span>
				          <span class="collapsing-headingQuestion">Are there bioequivalence data with Oxycontin?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse3" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading3">
				      <div class="collapsing-body">
				        <p>Yes, data from twelve bioequivalence studies comparing Abtard with the reference product were submitted in support of the application for marketing authorisation. (A formal response summarising the data can be found attached to SS/06/10/15/053/A08)</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-1">
				    <div class="collapsing-heading" role="tab" id="heading4">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse4" aria-expanded="false" aria-controls="collapse4">
				          <span class="collapsing-headingName">Abtard</span>
				          <span class="collapsing-headingQuestion">Is Abtard monophasic or biphasic?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse4" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading4">
				      <div class="collapsing-body">
				        <p>Abtard prolonged–release tablets are bioequivalent to Oxycontin prolonged-release tablets and are biphasic, meaning that there is an initial absorption of approximately 40% of oxycodone from the tablet providing onset of analgesia within one hour in most patients, followed by a more controlled absorption, which determines the 12-hour duration of action.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-2">
				    <div class="collapsing-heading" role="tab" id="heading5">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse5" aria-expanded="false" aria-controls="collapse5">
				          <span class="collapsing-headingName">Ebesque XL</span>
				          <span class="collapsing-headingQuestion">What are the dimensions of the tablets?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse5" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading5">
				      <div class="collapsing-body">
				        <p>They are a similar size to Seroquel.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-2">
				    <div class="collapsing-heading" role="tab" id="heading6">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse6" aria-expanded="false" aria-controls="collapse6">
				          <span class="collapsing-headingName">Ebesque XL</span>
				          <span class="collapsing-headingQuestion">Can the tablets be cut or split?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse6" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading6">
				      <div class="collapsing-body">
				        <p>No (unlicensed use); Ebesque XL is a prolonged release formulation. The SmPC states <span class="italic">“The tablets should be swallowed whole and not split, chewed or crushed.”</span></p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-2">
				    <div class="collapsing-heading" role="tab" id="heading7">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse7" aria-expanded="false" aria-controls="collapse7">
				          <span class="collapsing-headingName">Ebesque XL</span>
				          <span class="collapsing-headingQuestion">Can the tablets be stored in a dosette box/compliance aid?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse7" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading7">
				      <div class="collapsing-body">
				        <p>The Summary of Product Characteristics (SPC) for Ebesque XL states "Do not store above 30degC. This medicinal product does not require any special storage conditions". Unfortunately we do not have any additional stability data for transferring the product to a Dosing Unit box.  This would be outside the terms of the product licence storage recommdendations.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-2">
				    <div class="collapsing-heading" role="tab" id="heading8">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse8" aria-expanded="false" aria-controls="collapse8">
				          <span class="collapsing-headingName">Ebesque XL</span>
				          <span class="collapsing-headingQuestion">Are there bioequivalence data comparing Ebesque XL to other quetiapine XL products?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse8" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading8">
				      <div class="collapsing-body">
				        <p>Details of bioequivalence studies comparing Ebesque XL to Seroquel XL, can be found in the Ebesque XL Public Assessment Report as published on the MHRA website. <a href="http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con459432.pdf">http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con459432.pdf</a></p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-2">
				    <div class="collapsing-heading" role="tab" id="heading9">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse9" aria-expanded="false" aria-controls="collapse9">
				          <span class="collapsing-headingName">Ebesque XL</span>
				          <span class="collapsing-headingQuestion">Are there bio-equivalence data to show that 3 x 50mg Ebesque is equivalent to a single 150mg Seroquel XL?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse9" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading9">
				      <div class="collapsing-body">
				        <p>No bioequivalence studies specifically assessed this comparison.  Under the regulatory guidelines, it is usual to demonstrate bio-equivalence on a dose to dose basis.</p>
				        <p>Occasionally companies will submit applications to show that two smaller strengths of a product are bioequivalent to a higher strength of a different product. This was not the case with Ebesque XL.<br>We, with our partners are working on a regulatory dossier for an Ebesque XL 150mg which we hope to make available in 2015.</p>
				        <p>We can say that we hold a product license for Ebesque XL 50mg which is bio-equivalent to Seroquel 50mg.  That leaves the question to the prescribing healthcare professional.  Would they give three Seroquel 50mg to achieve a 150mg dose? E.g. if they were out of stock of 150mg.  If they are prepared to take that route then taking three Ebesque XL 50mg would achieve the same clinical result.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-6">
				    <div class="collapsing-heading" role="tab" id="heading10">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse10" aria-expanded="false" aria-controls="collapse10">
				          <span class="collapsing-headingName">Eppinix XL</span>
				          <span class="collapsing-headingQuestion">Is Eppinix XL the same as Requip XL?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse10" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading10">
				      <div class="collapsing-body">
				        <p>Yes, Eppinix XL is bioequivalent to the brand originator product from Requip XL.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading11">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse11" aria-expanded="false" aria-controls="collapse11">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">Can a patient be switched directly from Butrans (buprenorphine) patches to Fencino (fentanyl) patches?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse11" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading11">
				      <div class="collapsing-body">
				        <p>The instructions in the Butrans SmPC on discontinuation/switching to an alternative analgesic patch should be followed (contact the MAH for further details if required).</p>
				        <p>Then initiate Fencino according to the instructions in our SmPC</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading12">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse12" aria-expanded="false" aria-controls="collapse12">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">The patches have been stored in the fridge by mistake, can they still be used?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse12" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading12">
				      <div class="collapsing-body">
				        <p>From the SmPC : <span class="italic">“This medicinal product does not require any special storage conditions.”</span></p>
				        <p>Our understanding is as long as the product has not been frozen we don’t believe that the adhesion would be affected by storing it in a fridge.  However, we have no specific evidence relating to Fencino being stored in a fridge.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading13">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse13" aria-expanded="false" aria-controls="collapse13">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">Do the patches have to be stored flat?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse13" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading13">
				      <div class="collapsing-body">
				        <p>Fencino Patches are matrix not reservoir patches, so contain no "bulging" volume of liquid. There is no such requirement.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading14">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse14" aria-expanded="false" aria-controls="collapse14">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">Can Fencino be used by patients allergic to sticking plasters?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse14" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading14">
				      <div class="collapsing-body">
				        <p>Suggest that patients discuss this issue with their doctor/ prescriber as in our experience patients with genuine allergy to plasters are likely to have the same allergy to Fencino or any other transdermal patch.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading15">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse15" aria-expanded="false" aria-controls="collapse15">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">Should the patch be removed before an MRI scan?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse15" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading15">
				      <div class="collapsing-body">
				        <p>Fencino patches contain no metal whatsoever, other than in the peel-off foil, so there is no contra-indication with undergoing an MRI scan. Patients should be referred to their doctor for advice. For HCPs – see below</p>
				        <p>From a safety perspective, the SPC information around increased absorption of fentanyl with raised skin temperature should be given.</p>
				        <ul>
				        	<li>Although MRI doesn’t usually induce heat, some patients do report sensations of increased skin temperature or warming (particularly larger patients and/or if the skin touches the drum at all), so this is a possibility, and the associated adverse effects such as drowsiness and nausea may need to be considered or discussed with the patient.</li>
				        	<li>In addition, the Durogesic SPC (but not the Fencino SPC) contains a precaution about applying the patch to irradiated skin, presumably as irradiated skin may be more sensitive, increasing the risk of a local skin irritation reaction to the patch.</li>
				        	<li>Finally, increased skin temperature and perspiration may affect the adhesion of the patch.</li>
				        </ul>
				        <p>A pragmatic approach may be to remove the existing patch prior to the scan, provided the patch has been on for not less than 48 hours – see Section 4.2 Posology and method of administration and apply a new patch to a new area of skin (ensuring there are no microlesions or irritations on the new application area) after the MRI scan. Alternatively, if the patch has been on for less than 24 hours and they want to remove it, they may wish to wait for 12 -24 hours before applying the new patch. Either way, we are unable to give medical advice, so this decision must be made by the prescribing physician.</p>
				        <p>Section 4.2 (Posology), Section 4.4 (Warnings & Precautions) and Section 5.2 (Pharmacokinetics) all refer to fentanyl serum concentrations reducing gradually after the patch is removed (50% reduction in ~17 hours).</p>
				        <p>o   Section 5.2 also refers to the relatively constant rate of release of active ingredient due to the releasing polymer matrix and the diffusion of active ingredient through the layers of the skin, but mentions that a pharmacokinetic model has suggested that serum fentanyl concentrations may increase by 14% (0-26%) if a new patch is applied after 24 hours rather than the recommended 72 hours (possibly due to the concentration gradient between the patch and the skin).</p>
				        <p>The prescribing physician should therefore make the decision as to whether it is best for the patient to keep the patch on or remove it during the MRI scan. The patient should be advised accordingly about potential changes in absorption and consequences thereof, and the physician should also ensure that the patient has adequate pain relief – it may be necessary to use additional or alternative pain relief to manage breakthrough pain if removing the patch.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading16">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse16" aria-expanded="false" aria-controls="collapse16">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">Do the patches contain latex?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse16" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading16">
				      <div class="collapsing-body">
				        <p>No.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-3">
				    <div class="collapsing-heading" role="tab" id="heading17">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse17" aria-expanded="false" aria-controls="collapse17">
				          <span class="collapsing-headingName">Fencino</span>
				          <span class="collapsing-headingQuestion">Is the release rate 12mcg or 12.5mcg/hour?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse17" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading17">
				      <div class="collapsing-body">
				        <p>Fencino 12mcg has a release rate of approximately 12.5mcg per hour. The MHRA accepted the name Fencino 12mcg.</p>
				        <p>Part of the reason that the MHRA would allow Fencino 12mcg to be described as such is that the delivery rate at 12mcg is approximate although this isn’t mentioned on the individual packaging of the various forms of Fentanyl patches available on the UK market.  For example,  the SmPC for Durogesic 12mcg describes the delivery rate of 12mcg per hour as approximate.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-6">
				    <div class="collapsing-heading" role="tab" id="heading18">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse18" aria-expanded="false" aria-controls="collapse18">
				          <span class="collapsing-headingName">Glucosamine </span>
				          <span class="collapsing-headingQuestion">Supply/availability?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse18" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading18">
				      <div class="collapsing-body">
				        <p>Dallas Burston Healthcare and Herbaceutica Limited were sister companies to DB Ashbourne Ltd, both were selling non-licenced Glucosamine products with the brand names Meltdown and Cozachew. These products have been discontinued and are no longer available.</p>
				        <p>We refer any customers who contact us, to speak to their Community Pharmacist and our standard response is – <span class="italic">“No we cannot give any recommendation as to what alternative product to take, please speak with your Community Pharmacist”</span></p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading19">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse19" aria-expanded="false" aria-controls="collapse19">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">What is the sugar/carbohydrate content of the Venlalic XL 225mg tablets?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse19" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading19">
				      <div class="collapsing-body">
				        <p>Each 225mg tablet contains mannitol 5mg and microcrystalline cellulose 99.41mg. There is no fat in the list of ingredients.</p>
				        <p>Mannitol has a calorific value: 2.4 kcal/g. 0.12kcal per tablet</p>
				        <p>Microcrystalline cellulose (powder) is the bulk ingredient of the tablet and has no protein/fat or carbohydrate content</p>
				        <p>Our regulatory department informed me that if Venlalic XL was a food, it would be labelled as having negligible content of protein, fat and carbohydrate and zero calories.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading20">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse20" aria-expanded="false" aria-controls="collapse20">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">Why are the tablets being excreted in faeces (ghost tablets)?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse20" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading20">
				      <div class="collapsing-body">
				        <p>Venlalic XL tablets (37.5mg – 75mg – 150mg – 225mg) use an osmatic based drug delivery system.  This system is manufactured by applying a semipermeable membrane around a core which includes the active substance and osmatic agent.  This semipermeable membrane allows water to pass into the core. A delivery hole is drilled through the membrane by a laser system for releasing the active substance dissolved through the membrane.</p>
				        <p>When the drug is released, the system including only the semipermeable membrane and a little amount of insoluble excipients is excreted in the faeces.  Patients are advised in section 4 of the Patient Information Leaflet:<br><span class="italic">“Do not be concerned if you see a tablet in your stools after taking Venlalic XL Tablets. As the tablet travels the length of your gastrointestinal tract, venlafaxine is slowly released. The shape of the tablet remains undissolved and is eliminated in your stools. Therefore, even though you may see a tablet in your stools, your dose of venlafaxine has been absorbed”</span>.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading21">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse21" aria-expanded="false" aria-controls="collapse21">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">Is Venlalic XL suitable for vegans?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse21" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading21">
				      <div class="collapsing-body">
				        <p>No animal ingredients are used in the manufacturing of Venlalic XL and the product is therefore suitable for a vegan.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading22">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse22" aria-expanded="false" aria-controls="collapse22">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">Are there any data describing long-term use?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse22" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading22">
				      <div class="collapsing-body">
				        <p>We do not have any data relating to the use of venlafaxine over the long term.  The product originator (Wyeth - now Pfizer) may have data not in the published domain</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading23">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse23" aria-expanded="false" aria-controls="collapse23">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">Is Venlalic XL suitbale for patients with nut allergy?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse23" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading23">
				      <div class="collapsing-body">
				        <p>There is no absolute contraindication.  The prescriber should look at the excipients listed in the SmPC and make their own clinical judgement as to whether the product is suitable.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading24">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse24" aria-expanded="false" aria-controls="collapse24">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">Can the tablets be dissolved in water?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse24" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading24">
				      <div class="collapsing-body">
				        <p>No (unlicensed). The SPC recommends that venlafaxine prolonged-release tablets be taken with food, at approximately the same time each day. Tablets must be swallowed whole with fluid and not divided, crushed, chewed, or dissolved.</p>
				      </div>
				    </div>
				  </div>
				  <div class="collapsing-item filter-selector-5">
				    <div class="collapsing-heading" role="tab" id="heading25">
				        <a role="button" data-toggle="collapse" data-parent="#accordion" class="collapsed" href="#collapse25" aria-expanded="false" aria-controls="collapse25">
				          <span class="collapsing-headingName">Venlalic XL</span>
				          <span class="collapsing-headingQuestion">Can the tablets be stored in dosette/compliance aids?</span>
				          <span class="collapsing-headingArrow"></span>
				        </a>
				    </div>
				    <div id="collapse25" class="panel-collapse collapse" role="tabpanel" aria-labelledby="heading25">
				      <div class="collapsing-body">
				        <p>No – Venlalic XL should be kept in its original packaging until ready for use.</p>
				      </div>
				    </div>
				  </div>

				</div>

			</div>
		</div>

	</div>


	<section class="section section--gray section-searchmore">
		<div class="container">
			<div class="row">
				<div class="col-xs-12">
					<div class="section-searchmore-title">Didn't find what you were looking for ?</div>
					<div class="section-searchmore-subtitle">Please feel free to contact us for any further question.<br>We are unable provide medical advice</div>
					<div class="section-searchmore-buttonzone">
						<a href="contact.html" class="btn btn-orange btn-large">Contact</a>
					</div>
				</div>
			</div>
		</div>
	</section>

	<section class="section section--purple section-adverseevent">
		<div class="container">
			<div class="row">
				<div class="col-xs-12 col-md-4">
					<div class="section-adverseevent-title">Report adverse events</div>
				</div>
				<div class="col-xs-12 col-md-4">
					<p>Reporting forms and information can be found at:<br><span class="go-modal" data-toggle="modal" data-target=".worldwide-modal">www.mhra.gov.uk/yellowcard</span></p>
					
					<!-- <button type="button" class="btn btn-large btnWorld" data-toggle="modal" data-target=".worldwide-modal">Learn more</button> -->
					<div class="modal fade worldwide-modal" tabindex="-1" role="dialog" aria-labelledby="worldwide-modal">
						<div class="modal-dialog modal-md" role="document">
							<div class="modal-content">
								<p>You are now leaving Ethypharm UK and will be redirected to Ethypharm Global website</p>
								
								<div>
									<button type="button" class="btn btn-purplelite" data-dismiss="modal" aria-label="Close">Cancel</button>
									<a href="http://www.mhra.gov.uk/yellowcard" class="btn btn-purple">OK</a>
								</div>
							</div>
						</div>
					</div>

					<p>Adverse events should be reported to Ethypharm UK Ltd</p>
					<ul>
						<li><span class="bold">Telephone</span><br>0870 192 3283</li>
						<li><span class="bold">Email</span><br><a href="mailto:enquiries@medinformation.co.uk">enquiries@medinformation.co.uk</a></li>
					</ul>
				</div>
				<div class="col-xs-12 col-md-4">
					<p>Healthcare professionals medical information</p>
					<p>Any personal data you share with us will remain condidential at all times.</p>
					<p>Medical enquiries can be directed to the medical information department using the form below:</p>
					<ul>
						<li><span class="bold">Download</span><br><a href="docs/Medical_Information_Enquiry_Form_v7_16th_February_2015.docx">Medical Enquiry Form</a></li>
					</ul>
				</div>
			</div>
		</div>
	</section>

	</div>



	<!-- FOOTER -->
	<div class="container">
		<div class="row">

			<div class="col-xs-12">
				<footer class="footer">

					<div class="row">


						<div class="col-xs-12 col-md-3">
							<div class="footer-listTitle"><a href="homepage-pro.html"><i class="i-puce"></i> Healthcare professionals</a></div>
							<ul class="footer-list">
								<li><a href="prescribing-infos.html">Prescribing informations</a></li>
								<li><a href="product.html">Products</a></li>
								<li><a href="cost-saving-calculator.html">Cost savings calculator</a></li>
							</ul>
						</div>

						<div class="col-xs-12 col-md-3">
							<div class="footer-listTitle"><a href="homepage-public.html"><i class="i-puce"></i> Patients & members of the public</a></div>
							<ul class="footer-list">
								<li><a href="therapeutic-areas.html">Therapeutic Areas</a></li>
								<li><a href="faq.html">Frequently Asked Questions</a></li>
							</ul>
						</div>

						<div class="col-xs-12 col-md-4">
							<div class="footer-listTitle">
								<i class="i-puce"></i> Products
								<a class="footer-listTitle-arrows js-footerCollapse" role="button" data-toggle="collapse" href="#collapseFooter" aria-expanded="false" aria-controls="collapseFooter">
									<i class="i-arrow-top hidden"></i>
									<i class="i-arrow-bottom"></i>
								</a>
							</div>

							<div class="collapse out" id="collapseFooter">

								<div class="row">
									<ul class="col-xs-12 col-sm-3 footer-list">
										<li><a href="product-fencino.html">Fencino</a></li>
									</ul>
									<ul class="col-xs-12 col-sm-3 footer-list">
										<li><a href="product.html">Venlalic</a></li>
									</ul>
									<ul class="col-xs-12 col-sm-3 footer-list">
										<li><a href="product-abtard.html">Abtard</a></li>
									</ul>
									<ul class="col-xs-12 col-sm-3 footer-list">
										<li><a href="product-ebesque.html">Ebesque</a></li>
									</ul>
								</div>

							</div>

						</div>

						<div class="col-xs-12 col-md-2">
							<div class="footer-listTitle"><a href="contact.html"><i class="i-puce"></i> Contact</a></div>
						</div>

					</div>

				</footer>
			</div>

		</div>
	</div>



	<div class="terms">
		<div class="container-fluid">
			<div class="row">

				<div class="col-xs-12">
					<ul class="termsList">
						<li><a href="#">Terms and conditions Privacy</a></li>
						<li><a href="#">Copyright - DBAshbourne - 2016</a></li>
					</ul>
				</div>

			</div>
		</div>
	</div>

	<!-- JS -->
	<script type="text/javascript" src="js/jquery.min.js"></script>
	<script type="text/javascript" src="js/bootstrap.min.js"></script>
	<script type="text/javascript" src="js/fancyselect.js"></script>
	<script type="text/javascript" src="js/main.js"></script>

</body>
</html>